Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 13, Status: Authorised | Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 13, Status: Authorised | | Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Diabetes Mellitus, Type 2, Date of authorisation: 18/09/2013, Revision: 10, Status: Authorised | Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Diabetes Mellitus, Type 2, Date of authorisation: 18/09/2013, Revision: 10, Status: Authorised | | |